Analysts/Institutional Investor Meet/Con. Call Updates

Date: November 06, 2026 National Stock Exchange of India Ltd., BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra (E), Mumbai – 400 051 Mumbai- 400001 NSE Scrip Symbol: PRASOLCHEM BSE Scrip Code: 544912 Dear Sir/Madam, Sub: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Quarterly Earnings Conference Call held for Q2 FY27 results With reference to our letter dated October 29, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the transcript of the conference call with analysts and investors held on Tuesday, November 03, 2026 to discuss the Q2 FY27 results. The transcript is also being uploaded on the company’s website at https://www.prasolchem.com/investor- relations/ We request you to please take the same on record. Thanking You, Yours Sincerely, FOR PRASOL CHEMICALS LIMITED KIRAN RAJENDRA AGRAWAL Company Secretary & Compliance Officer Membership No. : A13188 Encl: a/a “Prasol Chemicals Limited Q2 FY27 Earnings Call” November 03, 2026 “E&OE - This transcript is edited for factual errors. In case of discrepancy, the audio recordings uploaded on the stock exchange on 3rd November 2026 will prevail.” MANAGEMENT: MR. NISHITH SHAH – CHAIRMAN AND WHOLE-TIME DIRECTOR MR. DHAVAL PARIKH – JOINT MANAGING DIRECTOR MR. PANKIL DHARIA – WHOLE-TIME DIRECTOR MR. RAHUL SHROFF – CHIEF FINANCIAL OFFICER MODERATOR: MR. KARAN TALWAR – DAM CAPITAL ADVISORS Page 1 of 12 Prasol Chemicals Limited November 03, 2026 Moderator: Ladies and gentlemen, good day and welcome to Prasol Chemicals Limited Q2 FY27 Earnings Call hosted by DAM Capital Advisors Limited. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the opening remarks. Should you need assistance during the conference call, please signal an operator by pressing star then 0 on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Karan Talwar from DAM Capital Advisors. Thank you, and over to you. Karan Talwar: Thanks, Iqra. Good morning everyone, and a very warm welcome to Prasol Chemicals Limited's Q2 FY27 post-earnings call. On behalf of DAM Capital Advisors, we thank the management for providing us with this opportunity. On the call today representing Prasol Chemicals Limited, we have Mr. Nishith Shah, Chairman and Whole-Time Director, Mr. Dhaval Parikh, Joint Managing Director, Mr. Rahul Shroff, Chief Financial Officer, and other senior members of the management team. I would like to hand over the call now to Mr. Nishith Shah for his opening remarks, following which we will open the floor for Q&A. Thank you, and over to you, sir. Nishith Shah: Good morning everyone. A very warm welcome to the Q2 and H1 FY27 earnings call of Prasol Chemicals Limited. As discussed by DAM, I am joined by my Joint MD, Mr. Dhaval Parikh, our Financial Director, Mr. Rahul Shroff, our Whole-Time Director, Pankil Daria, senior members of the team along with SGA, our Investor Relations Advisor, and DAM Capital, who has been our banker to the issue. I hope you had an opportunity to review our financial results and investor presentations which are available on the stock exchange and on Prasol's website. Before discussing our Q2 performance, I would like to reiterate what we had discussed in the earlier call regarding the Q1 FY27 earnings call. First and foremost, I would like, for benefit of all, to reiterate that in Q1 we had an exceptional pricing environment wherein, due to inventory gain, the company had earned INR25 crores extra, which was contributed due to the inventory gain due to the West Asia war, which was discussed with all the stakeholders. So basically, all our figures will be now talking in the range of 240 to 250 EBITDA for the annual thing, without the INR25 crores gain that we had got in So to bring everyone on the same page, kindly please understand that when I refer to 240 to 250 I am talking on the actual EBITDA the way we see the company would have done, not taking into account the inventory gain which we had made. We had guided an annual revenue of INR550 crores to INR1,650 crores, and an EBITDA, as I said now, of INR240 crores to INR250 crores, excluding any gains arising from the geopolitical price movements and forex fluctuation. I am very happy to announce that this has been one of our best Q2 of Prasol ever. Generally, we see that Q2 is slightly softer than Q1, and Q4 is generally the best of all the quarters. We have delivered a record quarterly revenue of INR413 crores, registering a year-to- year growth of around 38.6%. We are diversified by design, and despite the geopolitical headwinds, because of which the company has done exceptionally well and continues to grow Page 2 of 12 Prasol Chemicals Limited November 03, 2026 as per the guidelines given 6 to 8 months ago, raw material prices continue to remain elevated during the quarter. We have continued to diversify our raw material sourcing base on which we have engaged new suppliers and have increased our customer base across various geographies. So not only have we increased our customer base, but we have also increased the supplier base, keeping in mind the volatility and availability of raw material. With respect to acetone, additional domestic capacities are expected to come on stream starting January 2027. Further, our plans are to develop a storage facility at Khopoli, which will provide us great flexibility to procure material in bulk and optimize the logistic cost as well as the raw material cost. A diversified product portfolio at both facilities continue to contribute to the overall performance during this quarter as well. Progress on expansion plans. During our previous earning calls, we outlined that Phase 1 capital expenditure program would be approximately in the range of INR250 to INR300 crores. And focus on this expansion, we have already invested about INR75 crores so far and we will be investing roughly INR75 to INR100 crores before the end of the year. We will, in the process, we will be completing about 25% to 30% of the envisaged expansion products that we have been talking of existing products. Basically, by next year, half year, we will be completing another 25% to 30% and so on and so forth. So, the company will constantly continue on its path of growth and investment that it has promised. And I think things are going quite well as per what we had envisaged. All these projects in Phase 1 is likely to add about 60,000 tons of additional capacity, taking our overall installed capacity to 150,000 to 160,000 over the next 12 to 24 months. Beyond the Phase 1, we are also on track for Phase 2 investments of approximately INR250 crores to INR300 crores, which will focus on developing new R&D-led products with better margin potential, leveraging our existing plots of adjacent land bank that we have already purchased. Looking ahead, the global operational environment remains dynamic, volatile, as we may call. At the same time, demand from both domestic and international customers remains healthy and our order book continues to be strong. In fact, you will be happy to know that even going forward, the last month we have registered the highest sale ever in Prasol. We expect export performance to improve as shipping availability and freight conditions normalize. The price increase undertaken across our product portfolio should also support profitability, while the capacities being added through our expansion program are expected to contribute incrementally over the coming years. Based on our current assessment, we remain on track for our '27 guidelines of a revenue which I am repeating in the range of INR1,550 to INR1,650 crores, EBITDA of INR240 to INR250 crores, approximately 70% to 75% EBITDA [Showing first 8,000 characters — download PDF for full document]